Rapid Micro Biosystems, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Rapid Micro Biosystems, Inc. (RPID) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$5.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-07
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$6.21M, a 411.53% decline year-over-year.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $2.00M.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$1.85M.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$2.65M.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $3.04M.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$7.29M.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$2.78M.
- Rapid Micro Biosystems, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$151.32M, a 201.91% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.34M 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | -$6.21M 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $3.04M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $1.95M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $1.34M 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | $2.00M 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$7.29M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | -$2.24M 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $12.84M 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | -$1.85M 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | -$2.78M 10-K · filed 2025-02-28 | |||
| 2023-09-30 | -$3.28M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $1.62M 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | -$2.65M 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | -$151.32M 10-K · filed 2024-03-01 | |||
| 2022-09-30 | -$152.56M 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | -$128.67M 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | -$115.89M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $148.49M 10-K · filed 2023-03-10 | |||
| 2021-09-30 | $189.69M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $70.15M 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $78.56M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $17.57M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $12.81M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $21.80M 10-Q · filed 2021-08-27 |